| Patients and Family Members
More information. More informed choices.
Clozapine is an important treatment option for patients who have failed to respond to first- and second-line treatments for schizophrenia. However, its use has been limited by the significant risk of agranulocytosis, a rare but life-threatening condition.
PGxPredict™:CLOZAPINE provides information about a patient’s risk of developing clozapine-induced agranulocytosis. It’s a simple blood test that can provide relevant and important treatment information.
How it works:
- Your doctor collects a blood sample via a finger stick and sends it to our lab for analysis.
- Test results are returned directly to your doctor within 2 weeks.
- The results designate a patient as having either a higher risk or lower risk of developing clozapine-induced agranulocytosis.
- You and your doctor can use the results to help determine the best course of action.
Talk to your doctor to learn more about how PGxPredict™:CLOZAPINE may be able to help you or someone you care about.
|
